You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

248 Results
Guidelines and Advice
Status: Current
ID: 26-3
Version: 2
Feb 2024
Guidelines and Advice
Status: Current
ID: 7-11
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
Version: 2
Oct 2018
Guidelines and Advice
Status: Archived
ID: 7-15
Version: 2
Jan 2014
Guidelines and Advice
Status: In-Review
ID: 7-22
Aug 2015
Guidelines and Advice
Status: In-Review
ID: 7-21
May 2016
Guidelines and Advice
Status: Current
ID: 7-16
Version: 4
Dec 2022
Guidelines and Advice
Status: Current
ID: GL END 7-24
Nov 2024
Guidelines and Advice
Status: Archived
ID: CED 21
Jan 2011
Guidelines and Advice
Status: In-Review
ID: GL END 7-13-2
Version: 2
Nov 2019
Guidelines and Advice
Status: In-Review
ID: GL END 7-3
Version: 4
Apr 2020
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
amivantamab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2023

Pages